(Q37904546)

25 August 2017

1 reference

title

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2). (English)

1 reference

25 August 2017

1 reference

1

J A Washington

1 reference

25 August 2017

W R Wilson

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 April 1985

1 reference

25 August 2017

1 reference

25 August 2017

volume

60

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

271-278

1 reference

Clinical spectrum of erythromycin as evaluated in two hundred sixty patients

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

7 January 2021

Erythromycin--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Erythromycin therapy twice daily for streptococcal pharyngitis. Controlled comparison with erythromycin or penicillin phenoxymethyl four times daily or penicillin G benzathine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antimicrobial treatment of pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Bactericidal action of an average dose of erythromycin in the bronchi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Erythromycin succinate in the treatment of acute exacerbations of chronic bronchitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Treatment of bacterial pneumonia with erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Laboratory and clinical studies on erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

The treatment of bacterial pneumonia with erythromycin: a controlled clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Legionnaires' Disease: Clinical Features of the Epidemic in Philadelphia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Clinical aspects of Legionnaires' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Legionnaires' Disease in Patients with Associated Serious Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

The Compromised Host and Legionnaires' Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

7 January 2021

Eaton agent pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Chlamydial infections (first of three parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Otitis media of infancy and early childhood. A double-blind study of four treatment regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antibiotic prophylaxis in surgical procedures. A critical analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

A Survey of Clinical Trials of Antibiotic Prophylaxis in Colon Surgery: Evidence against Further Use of No-Treatment Controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Hepatotoxicity of Erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Chemical structure of erythromycin and hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Letter: Effect of benzodiazepines in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Group G streptococcal bacteremia: clinical study and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Decline of the hospital Staphylococcus? Incidence of multiresistant Staph. aureus in three Birmingham hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In Vitro Activity of Rosaramicin Against Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Susceptibility of Related Vibrios and Vibrio Fetus to Twelve Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

A comparison of the in vitro activity of rosamicin, erythromycin, spiramycin, penicillin and tetracycline against N. gonorrhoeae, including β-lactamase producing isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Legionella wadsworthii species nova: a cause of human pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antibiotic Susceptibility Testing of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Susceptibility of Beta-Hemolytic Streptococci to 65 Antibacterial Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In vitro susceptibility of Haemophilus influenzae to eight antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Infections caused by Rhodochrous

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Comparative Susceptibility of Penicillinase-Positive and -Negative Neisseria gonorrhoeae to 30 Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

The susceptibility of Bacteroides fragilis to 24 antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antibiotic susceptibility of black-pigmented Bacteroides isolates from the human oral cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antibiotic Susceptibility of Streptococcus mutans : Comparison of Serotype Profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Legionella longbeachae species nova, another etiologic agent of human pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Serious infection with Leptotrichia buccalis. Report of a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Susceptibility of clinical isolates of Staphylococcus saprophyticus to fifteen commonly used antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Endocarditis Due to Kurthia bessonii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Activity of nine antimicrobial agents against Lancefield group C and group G streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In Vitro Activity of Rosamicin Against Neisseria and Haemophilus , Including Penicillinase-Producing Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Acute and subacute endocarditis due to Erysipelothrix rhusopathiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Susceptibility of anaerobic bacteria to 23 antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

In Vitro Activity of Antimicrobial Agents on Legionnaires Disease Bacterium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Disk diffusion susceptibility testing of Nocardia species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Effect of preoperative antibiotic regimen on development of infection after intestinal surgery: Prospective, randomized, double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

Susceptibility of recent clinical isolates of Streptococcus pneumoniae to 17 antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960322-X

10.1016/S0025-6196(12)60322-X

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference